Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Presentation crawled time : 14:20 save search
Rackspace Technology Works with CCS Presentation Systems to Complete Complex Cloud Transition and Improve Security, Scalability, and Productivity for the Leading Audio-visual Integrator
Published: 2023-05-23 (Crawled : 14:20) - globenewswire.com
RXT | $1.565 2.96% 2.88% 750K
|
Technology Services
|
| O: -0.69%
H: 15.38%
C: -1.4%
presentation works cloud technology productivity
Karyopharm Announces Presentation of Interim Data from Phase 2 Study of Single-Agent Eltanexor in Relapsed/Refractory (R/R) Higher-Risk Myelodysplastic Neoplasms (MDS) at 17th International Congress on MDS
Published: 2023-05-03 (Crawled : 14:20) - biospace.com/
KPTI | $1.265 -8.33% -9.09% 1.3M
|
Health Technology
|
| O: 0.56%
H: 4.86%
C: 1.67%
presentation international study
Brickell Biotech Selected for a Late-Breaking Oral Presentation of US Phase 3 Pivotal Cardigan I and Cardigan II Study Results for Sofpironium Bromide Gel, 15% at the 2022 AAD Annual Meeting
Published: 2022-03-10 (Crawled : 14:20) - globenewswire.com
BBI | $2.12 16.04%
|
Health Technology
|
| O: -2.13%
H: 13.04%
C: 6.61%
biotech presentation meeting results study
IN8bio Announces Oral Presentation of New INB-200 Phase 1 Data in Glioblastoma (GBM) to be Presented at 2023 ASCO Annual Meeting
Published: 2023-04-26 (Crawled : 14:20) - globenewswire.com
INAB | $1.04 4.0% 3.85% 130K
|
|
| O: 4.71%
H: 9.5%
C: -2.5%
inb-200 presentation asco meeting glioblastoma
Allogene Therapeutics Announces Presentation of Phase 1 Data from the ALLO-501/501A Trials in Large B Cell Lymphoma at the American Society of Clinical Oncology (ASCO) Annual Meeting
Published: 2023-04-26 (Crawled : 14:20) - globenewswire.com
ALLO | $3.455 -1.57% -1.59% 1.2M
|
Health Technology
|
| O: 0.18%
H: 1.96%
C: -3.21%
allo-501 presentation cell trials meeting therapeutics
TG Therapeutics Announces Presentation of Data from the ULTIMATE I & II Phase 3 Trials of BRIUMVI® (ublituximab-xiiy) in Multiple Sclerosis at the American Academy of Neurology 75th Annual Meeting
Published: 2023-04-25 (Crawled : 14:20) - biospace.com/
TGTX | News | $14.0 1.3% 1.29% 3.5M
|
Health Technology
|
| O: 0.09%
H: 8.17%
C: -1.19%
briumvi presentation sclerosis trials meeting therapeutics
GeoVax Announces Presentation of Preliminary Data from Clinical Trial of Next-Generation COVID-19 Vaccine Candidate
Published: 2023-04-06 (Crawled : 14:20) - globenewswire.com
GOVX | $1.54 5.48% 5.19% 22K
|
Health Technology
|
| O: -0.7%
H: 4.23%
C: 1.69%
covid-19 candidate vaccine presentation trial
Ryman Hospitality Properties, Inc. Provides Investor Presentation Ahead of Raymond James & Associates’ 44th Annual Institutional Investor Conference
Published: 2023-03-06 (Crawled : 14:20) - globenewswire.com
RHP 4 | $104.58 -1.7% 0.0% 610K
|
Finance
|
| O: 1.18%
H: 0.54%
C: -0.71%
conference presentation
Borr Drilling Limited - Q4 2022 Presentation
Published: 2023-02-16 (Crawled : 14:20) - prnewswire.com
BORR | $5.51 -3.84% 0.91% 3.4M
|
Industrial Services
|
| O: -0.59%
H: 7.58%
C: 5.3%
presentation
SFL - Fourth Quarter 2022 Results Presentation
Published: 2023-02-15 (Crawled : 14:20) - globenewswire.com
SFL | $12.46 -1.11% 0.0% 820K
|
Transportation
|
| O: 1.93%
H: 0.76%
C: -1.42%
presentation results
VBI Vaccines Announces Presentation of Interim Phase 2 Data Evaluating Combination of VBI-2601 (BRII-179) and BRII-835 for the Treatment of Chronic Hepatitis B
Published: 2023-02-15 (Crawled : 14:20) - biospace.com/
VBIV | $0.6001 -1.46% -1.48% 180K
|
Health Technology
|
| O: -0.16%
H: 0.0%
C: -4.19%
vbi-2601 treatment hepatitis brii-835 presentation chronic hepatitis b
ImmunityBio Announces Presentation at ASCO GI 2023 of Fully Enrolled Trial in Third-Line and Greater Pancreatic Cancer and Update on FDA Type B Meetings Regarding Paths to Registration
Published: 2023-01-19 (Crawled : 14:20) - nantkwest.com
IBRX | $4.92 -6.11% -6.5% 3.5M
|
Manufacturing
|
| O: -1.1%
H: 1.11%
C: 0.22%
fda trial presentation asco update cancer pancreatic
Actinium Announces Phase 3 Iomab-B SIERRA Data Accepted for Late-Breaker Presentation at the Transplantation & Cellular Therapy Tandem Meetings
Published: 2023-01-12 (Crawled : 14:20) - biospace.com/
ATNM | $6.67 -8.0% 1.2% 420K
|
Health Technology
|
| O: 2.34%
H: 7.02%
C: 1.09%
presentation therapy
Cyclo Therapeutics Announces Abstract Accepted for Poster Presentation at the Society for Inherited Metabolic Disorders (SIMD) 44th Annual Meeting
Published: 2023-01-04 (Crawled : 14:20) - biospace.com/
CYTH | $1.22 0.83% 0.82% 30K
|
Professional, Scientific, and T...
|
| O: 4.45%
H: 3.83%
C: 3.83%
metabolic meeting therapeutics presentation
Cormedix Inc. Announces Presentation at Conference Showing Mortality Risk and Complications in Patients Experiencing Catheter Related Blood Stream Infections
Published: 2022-12-06 (Crawled : 14:20) - biospace.com/
CRMD | $5.42 -0.37% -0.37% 630K
|
Health Technology
|
| O: 0.91%
H: 0.0%
C: -10.41%
blood risk conference infections presentation
Borr Drilling Limited - Q3 2022 Presentation
Published: 2022-11-17 (Crawled : 14:20) - prnewswire.com
BORR | $5.51 -3.84% 0.91% 3.4M
|
Industrial Services
|
| O: -5.7%
H: 8.33%
C: 5.83%
presentation
GOGL – Q3 2022 Presentation
Published: 2022-11-16 (Crawled : 14:20) - globenewswire.com
GOGL | $13.05 -0.31% -0.31% 960K
|
Transportation
|
| O: -5.58%
H: 0.22%
C: -7.34%
presentation
Anixa Biosciences Announces Presentation on Breast Cancer Vaccine Trial at the 2022 San Antonio Breast Cancer Symposium
Published: 2022-11-08 (Crawled : 14:20) - biospace.com/
ANIX | News | $3.09 1.31% 1.29% 59K
|
Health Technology
|
| O: -1.5%
H: 2.67%
C: -1.15%
vaccine breast symposium trial presentation cancer
PDS Biotech Announces Abstract Demonstrating Versatility of the Versamune® Platform in Oncology Accepted for Presentation at AACR Special Conference on Tumor Immunology and Immunotherapy
Published: 2022-10-17 (Crawled : 14:20) - biospace.com/
PDSB | $2.89 6.25% 5.88% 1.1M
|
Health Technology
|
| O: 0.75%
H: 3.23%
C: 1.49%
versamune conference immunotherapy immunology biotech presentation platform
Aileron Therapeutics Announces Oral Presentation of Non-Clinical Data Demonstrating ALRN-6924 Protected Human Hair Follicles and Their Stem Cells from Chemotherapy-Induced Damage
Published: 2022-09-30 (Crawled : 14:20) - biospace.com/
ALRN | $5.01 17.88% 15.17% 1.8M
|
Health Technology
|
| O: -2.22%
H: 4.54%
C: -6.05%
alrn-6924 therapeutics presentation
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | News | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | News | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | News | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | News | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.